Related Experiment Video

Updated: May 18, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?

Tuba Cimilli Ozturk1, Erol Unluer, Arzu Denizbasi

  • 1Emergency Medicine Clinic, Umraniye Training and Research Hospital, Istanbul, Turkey.

Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
|September 14, 2012
PubMed

Insights

This study found that NT-proBNP levels are significantly higher in hospitalized congestive heart failure (CHF) patients compared to outpatients. This biomarker aids in diagnosing heart failure, especially in emergency settings.

Area of Science:

  • Cardiology
  • Biomarkers
  • Emergency Medicine

Background:

  • Heart failure (HF) presents a significant health challenge with a poor prognosis.
  • Echocardiography, the diagnostic gold standard for HF, has limitations in accessibility, particularly during emergencies.
  • N-terminal pro-brain natriuretic peptide (NT-proBNP) is an emerging biomarker for HF diagnosis, increasingly used in emergency departments.

Purpose of the Study:

  • To compare NT-proBNP levels in hospitalized congestive heart failure (CHF) patients versus outpatients.
  • To evaluate the utility of NT-proBNP as a diagnostic marker for heart failure.

Main Methods:

  • A single-center, prospective, controlled trial involving 92 patients diagnosed with decompensated heart failure.
  • Blood samples were analyzed for NT-proBNP using an immune fluorescent method.
  • Clinical data and NT-proBNP levels were compared between hospitalized and outpatient groups.

Main Results:

  • Hospitalized patients exhibited significantly higher NT-proBNP levels compared to outpatients.
  • A strong correlation was observed between NT-proBNP levels and the clinical status of patients.
  • Mean NT-proBNP was 9741.9 ± 8973 pg/ml in hospitalized patients versus 688.9 ± 284.5 pg/ml in non-decompensated CHF outpatients.

Conclusions:

  • NT-proBNP serves as a convenient diagnostic tool for congestive heart failure.
  • Further multi-center trials with larger cohorts are recommended to establish definitive NT-proBNP cut-off values.
Abstract

Keywords:
EmergencyHeart FailureNT-Pro-Brain Natriuretic Peptide

More Related Videos

Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure04:05

Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure

Published on: June 30, 2023

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.